This inventor holds 1 USPTO granted patent. Top assignee: Emet Pharmaceuticals, LLC. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Madurai Gurusamy Ganesan: Innovator in Delayed Release Pharmaceutical Compositions
Introduction
Madurai Gurusamy Ganesan is a notable inventor based in Newark, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of delayed release dosage forms. His innovative approach has the potential to enhance the efficacy of therapeutic drugs.
Latest Patents
Ganesan holds a patent for a delayed release pharmaceutical composition. This invention involves a solid dosage form that includes a core with a therapeutically effective amount of a drug, such as mesalamine. The composition features a pH-sensitive coating made from a mixture of two different pH-sensitive polymers. The first polymer dissolves in an aqueous solution at a pH of about 7 or greater, while the second polymer dissolves at a pH of about 6 or greater. The weight ratio of these polymers ranges from about 2:1 to about 4:1, and the weight gain from the pH-sensitive coating is between 8% and 15% of the core.
Career Highlights
Ganesan is associated with Emet Pharmaceuticals, LLC, where he applies his expertise in pharmaceutical innovations. His work focuses on improving drug delivery systems, which can lead to better patient outcomes. His patent reflects his commitment to advancing pharmaceutical technology.
Collaborations
Ganesan collaborates with talented professionals in his field, including Ramaswamy Balakrishnan and Nutan Kumar Gangrade. These collaborations enhance the research and development efforts at Emet Pharmaceuticals, LLC.
Conclusion
Madurai Gurusamy Ganesan is a distinguished inventor whose work in delayed release pharmaceutical compositions showcases his innovative spirit. His contributions to the field are paving the way for advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile